Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Was watching L2 like a hawk. Was going up & up. Went for a nap, came back - tank city !!!!!! Did real good on SUNE tho. Almost broke even.
Fold sure had some wild swings yesterday hope you made some $$$ . From central Alberta here
Perfect. Interesting. I find Questrade's platform almost impossible to use.
So, I use Investorline from Bank of Montreal. Much, much easier to use I find.
Thanks anywho..... fr: Sask.....SE corner
Hi Yes I use Questrade for pre market and after hours.
Girl, Please advise which brokerage you used and how much commission they charged you to buy premarket ?
Does anybody know if there is a Canadian broker that allows outside of regular hours trading ?
Nice trade by the way. Getting out at 9 ..... smoooooooth !!!!!
* * $FOLD Video Chart 10-02-15 * *
Link to Video - click here to watch the technical chart video
LOL! Bought in premarket at 5.95 and sold at 9 what a bounce!
My buy order @ $ 2
Sometimes I wonder if the FDA's function is to drive small bio-techs into bankruptcy with endless requests for additional studies. One day there will be no incentive to develop new drugs...unless of course you're a large pharmaceutical. We'll have a virtual monopoly led by a handful of companies.
$FOLD Perfect stock to own for 2-3 years. Amicus Therapeutics is a public American biopharmaceutical company based in Cranbury, New Jersey. The company went public in 2007 under the NASDAQ trading symbol FOLD. I personally bought in at $7.93 a share and foresee this OTC having massive upward growth potential with only a very little chance of a downside risk. This stock is currently owned and traded by the Nixon family and perceive this as to be a great stock for maximum growth being that the family see's its forecast being each share will be worth roughly an estimated $53.00 a share by 2017.
FOLD should rise to high 40s within a year according to Ronald Reagan's nephew whom I personally met on Steve Forbes Yacht party in Chicago this past June. Hold this bad boy or buy more, today is perfect to buy another 10k worth for me
$FOLD recent news/filings
bullish
## source: finance.yahoo.com
Mon, 08 Jun 2015 11:37:07 GMT ~ Amicus Therapeutics Strengthens Executive Leadership Team
[at noodls] - Adds Two Former Heads of Global Marketing From Leading Rare Disease Companies in Fabry Field Hung Do, Ph.D. Promoted to Chief Science Officer CRANBURY, N.J., June 8, 2015 (GLOBE NEWSWIRE) -- Amicus Therapeutics ...
read full: http://www.noodls.com/view/DC6E338B08CAE81919E32445EF676494A761C0A4
*********************************************************
Mon, 08 Jun 2015 11:30:00 GMT ~ Amicus Therapeutics Strengthens Executive Leadership Team
[GlobeNewswire] - Adds Two Former Heads of Global Marketing From Leading Rare Disease Companies in Fabry Field
read full: http://finance.yahoo.com/news/amicus-therapeutics-strengthens-executive-leadership-113000572.html
*********************************************************
Thu, 04 Jun 2015 10:02:15 GMT ~ AMICUS THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/150604/fold8-k.html
*********************************************************
Wed, 03 Jun 2015 11:21:10 GMT ~ Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union
[at noodls] - MAA Submission Under 'Accelerated Assessment' Brand Name Galafold™ Approved by Regulatory Authorities in EU and U.S. ... This is an abstract of the original noodl. To continue reading this document, click ...
read full: http://www.noodls.com/view/8B62861FB912359F54C457842FE8F45E81037D09
*********************************************************
Wed, 03 Jun 2015 11:00:00 GMT ~ Amicus Therapeutics Submits Marketing Authorization Application (MAA) for Full Approval of Fabry Monotherapy Galafold(TM) (Migalastat) in European Union
[GlobeNewswire] - MAA Submission Under "Accelerated Assessment"
read full: http://finance.yahoo.com/news/amicus-therapeutics-submits-marketing-authorization-110000478.html
*********************************************************
$FOLD charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$FOLD company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/FOLD/company-info
Ticker: $FOLD
OTC Market Place: Not Available
CIK code: 0001178879
Company name: Amicus Therapeutics, Inc.
Incorporated In: DE, USA
$FOLD share structure
## source: otcmarkets.com
Market Value: $1,262,153,272 a/o Jun 09, 2015
Shares Outstanding: 96,421,182 a/o Apr 24, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$FOLD extra dd links
Company name: Amicus Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=FOLD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=FOLD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=FOLD+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/news - http://finance.yahoo.com/q/h?s=FOLD+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/FOLD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=FOLD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/FOLD
DTCC (dtcc.com): http://search2.dtcc.com/?q=Amicus+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Amicus+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Amicus+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/FOLD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001178879&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=FOLD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=FOLD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=FOLD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=FOLD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=FOLD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=FOLD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=FOLD+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/FOLD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=FOLD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/FOLD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=FOLD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/FOLD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/FOLD/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/FOLD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/FOLD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/FOLD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=FOLD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=FOLD
$FOLD DD Notes ~ http://www.ddnotesmaker.com/FOLD
Greenpanda I apologize. I hit the wrong board and thought I was on the Apliphi board. I love this company as well and have been buying since just below $9. I am far from 100K share like I had mentioned but easily own over $100k worth.
Ok.. Well this is not a penny 2 me... Just a chance to make alot of money from BIO bubble this year IMO.. if u see a 1.2mill trade go through in a week u know who it was
i really want to buy 100k worth of this but... im still on fence on this 1
http://www.form4oracle.com/company?cik=0001178879&ticker=fold
http://www.investopedia.com/articles/stocks/07/10b5-1.asp
1. The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
2. This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
3. This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.98. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Those were planned sales. Primed for a buyout here IMO.
There wasn't alot. If I was a insider I would take some off the table. Taking a little profit I'd good if you know what I mean.
Yeah only thing scares me about this 1 is all the insiders dumping 2 weeks ago i dont like to see that
Thank you. Gl to you as well
im already covered and gone good luck to u
Come on man. Get real dude. Start helping the board with real information and not what you think. We don't care what you think. I'm not sell my shares I got
this is about to get real ugly... blood bath coming in a hour...
I think the stock will see 2 more red days and then go to a newer high... Shorts are also not always a bad thing... cover= increase in pps... good luck with your position i think long here is a good place to be .. i just missed the boat.. shorting biotech after huge gains is not a bad thing 2 do..
Sounds good. I agree we are all here to make money. It read fell 13% from the high. I may fall a little bit more but then continue its upward trend. I can see this on getting bought out. Just like everyone else I hope everything goes go and we kept work are way to higher highs and higher lows. :)
I think fold will do great things.. BB is invested cant be a joke? im here to make money on consolidation period... hope everything goes well for every long here... the stock will fall it went up to far thats the way the game goes... good luck bud
I'm sure many other CEO's of pre-revenue companies would be jealous. Obviously I was onto this stock a while back. That was the only issue I had with FOLD.
I say that is worth it for saving lives. He has worked really hard. A lot of people are just jealous. Fold is a billion dollar company. Just wait until they get bought out. I'm hoping for $20 a share or higher
Looks like the marketcap is growing into the CEO's salary.
Who is your news sources telling you this. I bet you are shorting fold trying to get a cheaper price. If you aren't going to be productive please leave the board. Maybe you should listen to the last conference call. This is going to do better then you think
What price did you get your 16k short?
dump starts monday.... last time i say
Maybe you should go back to the otc. This is a big boys stock.
What are you smoking can I have some of that. Good luck. after a big move up it usually is goes down then works it's way back up. Maybe you should be listening to the conference calls. I wouldn't be messing with shorting this.
Ok shortie. Nice guess. Good luck to ya
16K? Nice! at what price?
Gap to fill at $9.00? Wow ! Good luck!
Being short over the weekend? Good Luck!
EOD CRASH INC .... sry.. just imo i think big selloff around the courner gap fill at 9??
Thanks clay you are omen
But I swing traded my short overnight because of you thanks :)
Darn where have you been? Thought I would have seen you on the board when I caught it.
DMC is late to the party on this one? Didn't notice this til now...
* * $FOLD Video Chart 03-19-15 * *
Link to Video - click here to watch the technical chart video
Followers
|
55
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
495
|
Created
|
08/09/07
|
Type
|
Free
|
Moderators |
http://www.amicustherapeutics.com/
http://finance.yahoo.com/q/ks?s=FOLD
http://www.form4oracle.com/company?cik=0001178879&ticker=fold
http://moneycentral.msn.com/investor/invsub/insider/trans.asp?Symbol=FOLD
Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule, orally-administered drugs, known as pharmacological chaperones, for the treatment of a range of human genetic diseases. The pharmacological chaperone technology involves the use of small molecules to restore biological activity in cells by binding to a misfolded protein caused by a genetic mutation. The company is targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Its lead compound includes Amigal, which is in Phase II clinical trials is used for the treatment of Fabry disease that causes kidney failure, cardiac abnormalities, and neurological complications. The company is also developing AT2101 for the treatment of Gaucher disease, which causes an enlarged liver and spleen, low levels of red blood cells and platelets, bone pain, and fractures; and AT2220 for the treatment of Pompe disease, which causes muscle weakness primarily affecting breathing, mobility, and heart function. Amicus Therapeutics was founded in 2002 and is headquartered in Cranbury, New Jersey.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |